The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeabilityREIBER, H; SUCKLING, A. J; RUMSBY, M. G et al.Journal of the neurological sciences. 1984, Vol 63, Num 1, pp 55-61, issn 0022-510XArticle

Adjuvants and delivery systems in veterinary vaccinology: current state and future developmentsHEEGAARD, Peter M. H; DEDIEU, Laurence; JOHNSON, Nicholas et al.Archives of virology. 2011, Vol 156, Num 2, pp 183-202, issn 0304-8608, 20 p.Article

Vaccine with herbal adjuvant-A better cocktail to combat the infectionSAKURE, Sandhya; VIDYA DEVI NEGI; SHANKAR KUMAR MITRA et al.Vaccine. 2008, Vol 26, Num 27-28, pp 3387-3388, issn 0264-410X, 2 p.Article

The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARα-independent mechanismLARSEN, Søren Thor; NIELSEN, Gunnar Damgard.Toxicology letters. 2007, Vol 170, Num 3, pp 223-228, issn 0378-4274, 6 p.Article

Evaluation of widely consumed botanicals as immunological adjuvantsRAGUPATHI, Govind; YEUNG, K. Simon; LIVINGSTON, Philip et al.Vaccine. 2008, Vol 26, Num 37, pp 4860-4865, issn 0264-410X, 6 p.Article

Disparate adjuvant properties among three formulations of alumCAIN, Derek W; SANDERS, Sergio E; CUNNINGHAM, Michael M et al.Vaccine. 2013, Vol 31, Num 4, pp 653-660, issn 0264-410X, 8 p.Article

Co-stimulatory agonists as immunological adjuvantsBARR, Tom A; CARLRING, Jennifer; HEATH, Andrew W et al.Vaccine. 2006, Vol 24, Num 17, pp 3399-3407, issn 0264-410X, 9 p.Article

European union regulatory developments for new vaccine adjuvants and delivery systemsSESARDIC, Dorothea; DOBBELAER, Roland.Vaccine. 2004, Vol 22, Num 19, pp 2452-2456, issn 0264-410X, 5 p.Conference Paper

VACCINS Les adjuvants en renfort ! = Vaccins and adjuvants for enhancing immunityLARGETEAU, Quitterie.Découverte (Paris. 1999). 2012, Num 383, pp 26-35, issn 1621-0085, 10 p.Article

Preformulation studies—The next advance in aluminum adjuvant-containing vaccinesHEM, Stanley L; HOGENESCH, Harm; MIDDAUGH, C. Russell et al.Vaccine. 2010, Vol 28, Num 31, pp 4868-4870, issn 0264-410X, 3 p.Article

Vaccine AdjuvantsREED, Steven G.Expert review of vaccines. 2013, Vol 12, Num 7, issn 1476-0584, [112 p.]Serial Issue

ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases : Vaccines and AdjuvantsBAZ MORELLI, Adriana; BECHER, Dorit; KOERNIG, Sandra et al.Journal of medical microbiology. 2012, Vol 61, Num 7, pp 935-943, issn 0022-2615, 9 p.Conference Paper

The safety evaluation of adjuvants during vaccine development: The AS04 experienceGARCON, Nathalie; SEGAL, Lawrence; TAVARES, Fernanda et al.Vaccine. 2011, Vol 29, Num 27, pp 4453-4459, issn 0264-410X, 7 p.Article

Nanotechnology for vaccine developmentTOTH, Istvan; SKWARCZYNSKI, Mariusz.Nanomedicine (London. Print). 2014, Vol 9, Num 17, issn 1743-5889, [112 p.]Serial Issue

TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccinesTUDOR, Daniela; DUBUQUOY, Catherine; GABORIAU, Valérie et al.Vaccine. 2005, Vol 23, Num 10, pp 1258-1264, issn 0264-410X, 7 p.Article

Adjuvants in perspectiveVOGEL, F. R.Developments in biological standardization. 1998, Num 92, pp 241-248, issn 0301-5149Conference Paper

Structural modification effects on bioactivities of the novel 15-mer peptide adjuvantLAMAN, A. G; SHEPELYAKOVSKAYA, A. O; BOZIEV, Kh. M et al.Vaccine. 2011, Vol 29, Num 44, pp 7779-7784, issn 0264-410X, 6 p.Article

Carbohydrate moieties as vaccine candidates: Meeting summaryLUCAS, A. H; RITTENHOUSE-OLSON, K; KRONENBERG, M et al.Vaccine. 2010, Vol 28, Num 4, pp 1121-1131, issn 0264-410X, 11 p.Article

Chemical adjuvants for plasmid DNA vaccinesGREENLAND, John R; LETVIN, Norman L.Vaccine. 2007, Vol 25, Num 19, pp 3731-3741, issn 0264-410X, 11 p.Article

Synergism between active listeriolysin O and dimethyldioctadecylammonium bromide to activate CD8⁺ T cellsSMITH, Corey; CHEERS, Christina.Vaccine. 2005, Vol 23, Num 36, pp 4481-4488, issn 0264-410X, 8 p.Article

Adjuvant Trials of Targeted Agents: The Newest Battleground in the War on CancerCOHEN, Robert L.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 217-232, issn 0070-217X, 16 p.Article

Adjuvants in tuberculosis vaccine developmentMORENO-MENDIETA, Silvia A; ROCHA-ZAVALETA, Leticia; RODRIGUEZ-SANOJA, Romina et al.FEMS immunology and medical microbiology (Print). 2010, Vol 58, Num 1, pp 75-84, issn 0928-8244, 10 p.Conference Paper

Vaccine adjuvants revisitedAGUILAR, J. C; RODRIGUEZ, E. G.Vaccine. 2007, Vol 25, Num 19, pp 3752-3762, issn 0264-410X, 11 p.Article

Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid ATIBERIO, Lorrie; FLETCHER, Leah; ELDRIDGE, John H et al.Vaccine. 2004, Vol 22, Num 11-12, pp 1515-1523, issn 0264-410X, 9 p.Article

Mitogenic, immunoadjuvancy, and genetic studies on fatty acyl maltoseBISSONNETTE, E; BENREZZAK, O; MADARNAS, P et al.Cancer immunology and immunotherapy. 1988, Vol 27, Num 3, pp 272-277, issn 0340-7004Article